Search results
Results From The WOW.Com Content Network
Global tuberculosis cases reached an all-time high in 2023, with nearly 11 million people estimated to have become sick with the disease last year. According to the World Health Organization’s ...
Tuberculosis is back to being the leading infectious disease killer across the globe, surpassing COVID-19, according to a recent report from the World Health Organization.. Nearly 8.2 million ...
Tuberculosis (TB), also known colloquially as the " white death ", or historically as consumption, [8] is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. [1] Tuberculosis generally affects the lungs, but it can also affect other parts of the body. [1] Most infections show no symptoms, in which case it is known ...
The contagious disease was responsible for 1.25 million global deaths in 2023, WHO reported, including 161,000 people with HIV. COVID-19 had overtaken TB as the world’s leading infectious killer ...
The history of tuberculosis encompasses the origins of the disease, tuberculosis (TB) through to the vaccines and treatments methods developed to contain and mitigate its impact. Throughout history, the disease tuberculosis has been variously known as consumption, phthisis, and the White Plague. It is generally accepted that the causative agent ...
Mycobacterium tuberculosis (M. tb), also known as Koch's bacillus, is a species of pathogenic bacteria in the family Mycobacteriaceae and the causative agent of tuberculosis. [1][2] First discovered in 1882 by Robert Koch, M. tuberculosis has an unusual, waxy coating on its cell surface primarily due to the presence of mycolic acid.
The global fight against tuberculosis (TB), badly hit by the COVID-19 pandemic, is beginning to recover but remains a long way off target, according to a World Health Organization report. During ...
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB. The medical standard for active TB is a short course treatment involving a combination of isoniazid , rifampicin (also known as Rifampin), pyrazinamide , and ethambutol for the first two months.